Modern strategies in the prevention of implant-associated infections.
The application of medical devices either for temporary or permanent use has become an indispensible part of almost all fields of medicine. However, foreign bodies are associated with a substantial risk of bacterial and fungal infections. Implant-associated infections significantly contribute to the still increasing problem of nosocomial infections. To reduce the incidence of such infections, specific guidelines providing evidence-based recommendations and comprising both technological and nontechnological strategies for prevention have been established. Strict adherence to hygienic rules during insertion or implantation of the device are aspects of particular importance. Besides such basic and indispensable aspects, the development of new materials which could withstand microbial adherence and colonization has become a major topic in recent years. Modification of surface by primarily physico-chemical methods may lead to a change in specific and unspecific interactions with microorganisms and, thus, to a reduction in microbial adherence. Medical devices made out of a material that would be ideally antiadhesive or at least colonization-resistant would be the most suitable candidates to avoid colonization and subsequent infection. However, it appears impossible to create a surface with an absolute 'zero'-adherence due to thermodynamical reasons and due to the fact that a modified material surface is in vivo rapidly covered by plasma and connective tissue proteins. Therefore, another concept for the prevention of implant-associated infections involves the impregnation of devices with various antimicrobial substances such as antibiotics, antiseptics, and/or metals. In fact, already commercially available materials for clinical use such as antimicrobial catheters have been introduced, in part with considerable impact on subsequent infections. However, future studies are warranted to translate the knowledge on the pathogenesis of device-associated infections into applicable prevention strategies.
von Eiff
C
C
Institute of Medical Microbiology, University of Münster Hospital and Clinics, Münster, Germany. eiffc@uni-muenster.de
Kohnen
W
W
Becker
K
K
Jansen
B
B
D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D001422:Bacterial Adhesion; D020099:Coated Materials, Biocompatible; D004866:Equipment Contamination / Q000517:prevention & control; D006801:Humans; D017053:Infection Control / Q000592:standards*; D017410:Practice Guidelines as Topic; D011474:Prosthesis Design; D016459:Prosthesis-Related Infections / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D020099:Coated Materials, Biocompatible